Reuters was first to report Temasek Holdings is exploring selling Advanced MedTech, after the medical devices firm, fully owned by the Singaporean state investor, received interest from suitors, including buyout funds. Two investment banks have been tapped to launch a sale process for Singapore-headquartered MedTech, which could be valued at roughly $1 billion.
The post Reuters reveals Singapore’s Temasek considers sale of Advanced MedTech, likely valued at about $1 bln appeared first on Reuters News Agency.